689 - HHV-6 and EBV Reactivation after Allogeneic Hematopoietic Cell Transplantation in the Era of Letermovir for CMV Prophylaxis: A Retrospective Cohort Study

Thursday, October 20, 2022

12:15 PM – 12:45 PM US ET

Location: Hall BC - Arena 2

All relevant financial disclosures have been mitigated.

Rapid Fire Presenter(s)

Eleftheria Kampouri, MD

Post-doctoral research fellow
Fred Hutchinson Cancer Center
Seattle, WA, United States

Disclosure: Disclosure(s): No financial relationships to disclose

Co-Author(s)

EK

Elizabeth M. Krantz, M.S.

Statistical Research Associate
Fred Hutch Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Danniel Zamora, MD (he/him/his)

Infectious Diseases Acting Assistant Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
LK

Louise E. Kimball, PhD

PhD
Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
EK

Erika Kiem, n/a

Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
EL

Erika A. Lovas, n/a

Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
RB

Rachel Blazevic, BS

Program Assistant II
Fred Hutchinson Cancer Research Center
Seattle, WA, United States

Disclosure: Disclosure(s): No financial relationships to disclose
TS

Terry L. Stevens-Ayers, MS

Research Technician
Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
MH

Meei-Li Huang, PhD

Research Scientist
University of Washington
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
UM

Ueda Oshima Masumi, MD MA

Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
KJ

Keith R. Jerome, MD PhD

Professor
Fred Hutchinson Cancer Center
Seattle, Washington, United States

Disclosure: Disclosure(s): No financial relationships to disclose
Danielle M. Zerr, MD MPH

Professor Pediatric Infectious Diseases/Med. Dir. Infection Prevention
University of Washington; Seattle Children's Research Institute
Seattle, Washington, United States

Disclosure: Disclosure(s): AlloVir: Advisor/Consultant ()
Michael J. Boeckh, MD PhD

Professor
Fred Hutchinson Cancer Center
Seattle, WA, United States

Disclosure: Disclosure(s): Allovir: Advisor/Consultant (); Amazon: Grant/Research Support (); Ansun Biopharma: Grant/Research Support (); EvrysBio: Advisor/Consultant (); Gates Ventures: Grant/Research Support (); Gilead Sciences: Advisor/Consultant (), Grant/Research Support (); GlaxoSmithKline: Advisor/Consultant (), Grant/Research Support (); Helocyte: Advisor/Consultant (); Janssen: Advisor/Consultant (), Grant/Research Support (); Kyorin Pharmaceuticals: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Moderna: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); ReViral: Advisor/Consultant (); Symbio: Advisor/Consultant (); Takeda: Grant/Research Support (); Vir Biotechnology: Advisor/Consultant (), Grant/Research Support ()
Joshua A. Hill, MD

Assistant Professor
Fred Hutchinson Cancer Center; University of Washington
Seattle, Washington, United States

Disclosure: Disclosure(s): Allovir: Advisor/Consultant (), Grant/Research Support (); Covance/CSL: Advisor/Consultant (); CRISPR: Advisor/Consultant (); Deverra: Grant/Research Support (); Gilead: Grant/Research Support (); Karius: Advisor/Consultant (), Grant/Research Support (); Merck: Grant/Research Support (); Octapharma: Advisor/Consultant (); OptumHealth: Advisor/Consultant (); Oxford Immunotec: Grant/Research Support (); Pfizer: Advisor/Consultant (); Symbio: Advisor/Consultant (); Takeda: Advisor/Consultant ()

Disclosure(s):

Eleftheria Kampouri, MD: No financial relationships to disclose

Elizabeth M. Krantz, M.S.: No financial relationships to disclose

Danniel Zamora, MD: No financial relationships to disclose

Louise E. Kimball, PhD: No financial relationships to disclose

Erika Kiem, n/a: No financial relationships to disclose

Erika A. Lovas, n/a: No financial relationships to disclose

Rachel Blazevic, BS: No financial relationships to disclose

Terry L. Stevens-Ayers, MS: No financial relationships to disclose

Meei-Li Huang, PhD: No financial relationships to disclose

Ueda Oshima Masumi, MD MA: No financial relationships to disclose

Keith R. Jerome, MD PhD: No financial relationships to disclose

Danielle M. Zerr, MD MPH: AlloVir: Advisor/Consultant ()

Michael J. Boeckh, MD PhD: Allovir: Advisor/Consultant (); Amazon: Grant/Research Support (); Ansun Biopharma: Grant/Research Support (); EvrysBio: Advisor/Consultant (); Gates Ventures: Grant/Research Support (); Gilead Sciences: Advisor/Consultant (), Grant/Research Support (); GlaxoSmithKline: Advisor/Consultant (), Grant/Research Support (); Helocyte: Advisor/Consultant (); Janssen: Advisor/Consultant (), Grant/Research Support (); Kyorin Pharmaceuticals: Advisor/Consultant (); Merck: Advisor/Consultant (), Grant/Research Support (); Moderna: Advisor/Consultant (), Grant/Research Support (); Regeneron: Grant/Research Support (); ReViral: Advisor/Consultant (); Symbio: Advisor/Consultant (); Takeda: Grant/Research Support (); Vir Biotechnology: Advisor/Consultant (), Grant/Research Support ()

Joshua A. Hill, MD: Allovir: Advisor/Consultant (), Grant/Research Support (); Covance/CSL: Advisor/Consultant (); CRISPR: Advisor/Consultant (); Deverra: Grant/Research Support (); Gilead: Grant/Research Support (); Karius: Advisor/Consultant (), Grant/Research Support (); Merck: Grant/Research Support (); Octapharma: Advisor/Consultant (); OptumHealth: Advisor/Consultant (); Oxford Immunotec: Grant/Research Support (); Pfizer: Advisor/Consultant (); Symbio: Advisor/Consultant (); Takeda: Advisor/Consultant ()